Supply
30 Days
Format
Líquido liposomal
Serving
10 ml diarios
Made in Germany
Third-Party Tested
EU Compliant
SIRTCORE-01
NAD⁺ precursor & sirtuin activation
EU-authorised Nicotinamide Riboside (NR) 300 mg — a source of niacin contributing to normal energy-yielding metabolism and the reduction of tiredness and fatigue — with Zinc Bisglycinate 10 mg, Trans-Resveratrol 500 mg, and Quercetin 300 mg. Liquid liposomal delivery. Four compounds, clinical doses, full transparency.
or €41.65/mo with Subscribe & Save 15%
Free EU shipping · 30-day guarantee · Secure checkout
Made in Germany
Third-Party Tested
EU Compliant
GMP Certified
Questions
Science
Four precision-sequenced biological events that distinguish this formulation from commodity supplements.
Step 01
NR and zinc are wrapped in a phospholipid bilayer for protected delivery.
Step 02
The liposome shell shields actives from stomach acid degradation.
Step 03
Phospholipid fusion enables direct intracellular delivery of NR.
Step 04
NR serves as an EU-authorised source of niacin, supporting energy metabolism.
Formula
Clinical dosages. No proprietary blends. Complete transparency on every active.
| Ingredient | Origin | Clinical Dose | Primary Function | Delivery |
|---|---|---|---|---|
Nicotinamide Riboside (NR) Nicotinamide Riboside [] | Synthetic | 300 mg | EU-authorised source of niacin, contributing to normal energy-yielding metabolism | Liposomal |
Zinc Bisglycinate Zinc Bisglycinate [] | Synthetic | 10 mg | Contributes to the protection of cells from oxidative stress | Chelated form |
Trans-Resveratrol Trans-Resveratrol [] | Plant | 500 mg | Plant polyphenol | Liposomal |
Quercetin Quercetin [] | Plant | 300 mg | Plant flavonoid | Phospholipid complex |
Transparency
Verified supply chain documentation — not marketing copy.
Evidence
EFSA-registered health claims and peer-reviewed supporting literature. Every [n] in this page links here.
Chief Formulator
Moana Natura
Formulator's Commitment
“SirtCore 01 uses the full EU-authorised 300 mg NR dose — the only dose supported by Commission Regulation (EU) 2020/16.”
